CPR‑COV‑001
COVID‑19
PreclinicalActive
Key Facts
About Chugai Pharmabody Research
CPR pioneers antibody and cyclic peptide drug discovery to address unmet medical needs worldwide.
View full company profileTherapeutic Areas
Other COVID‑19 Drugs
| Drug | Company | Phase |
|---|---|---|
| SpikoGen® / Covax‑19 | Vaxine | Commercial |
| P-004 | Panacea Biotec | Phase 3 |
| FAVILOW | MSN Laboratories | Commercial |
| Movfor (Molnupiravir) | Hetero | Phase 3 |
| Nirmatrelvir/Ritonavir Generic | Hetero | Commercial |
| Oravax | Premas Biotech | Preclinical |
| SARS‑CoV‑2 Detection (TRURAPID®) | 3B BlackBio | Commercial |
| Antroquinonol (Hocena) | Golden Biotechnology | Phase 1/2 |
| AdCOV‑19 | Adimmune | Phase 1/2 |